Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Meislin

Sports Medicine New York, NY Medical Doctor

NPI 1225024631 CMS profile 146385

333 E 38Th St, 4Th Fl., New York, NY 10016

Open in the dashboard

General payments

$720,209

135 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$25,000

1 holding reported · through program year 2025

Through program year 2025, Robert Meislin of New York, NY is reported in the CMS Open Payments database as having received $720,209 across 135 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $25,000 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $116,449 13
2024 General $186,841 22
2023 General $41,733 25
2022 General $316,438 26
2021 General $28,493 27
2020 General $7,888 5
2019 General $22,369 17
2019 Ownership $25,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Meislin
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Robert Meislin were reported at $116,449. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Robert Meislin Sports Medicine median Middle half National median
2019 $22,369 $1,176 $199–$4,249 $163
2020 $7,888 $708 $96–$2,890 $114
2021 $28,493 $1,213 $152–$3,994 $132
2022 $316,438 $1,230 $159–$3,998 $149
2023 $41,733 $584 $146–$2,836 $160
2024 $186,841 $628 $163–$3,168 $164
2025 $116,449 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Linvatec Corporation $605,794 40 payments
  2. Medical Device Business Services, Inc. $56,161 42 payments
  3. DePuy Synthes Products, Inc. $27,294 18 payments
  4. Biorez, Inc. $17,600 3 payments
  5. Arcuro Medical Inc $6,200 5 payments
  6. Smith+Nephew, Inc. $3,104 12 payments
  7. Gotham Surgical Solutions & Devices, Inc. $1,468 2 payments
  8. Arthrex, Inc. $1,160 1 payment
  9. Pacira Pharmaceuticals Incorporated $408 1 payment
  10. Stryker Corporation $350 3 payments
  11. Other $671 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Acquisitions $555,203 9 payments
  2. Consulting Fee $145,586 49 payments
  3. Travel and Lodging $7,989 25 payments
  4. Food and Beverage $6,939 44 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,408 3 payments
  6. Education $1,484 4 payments
  7. Compensation for serving as faculty or as a speaker for a medical education program $600 1 payment
Products named General payments · program years 2019–2025
  1. BIOBRACE 23MM Orthopedic Surgery $605,648 39 payments
  2. HEALIX KNOTLESS PEEK $30,795 10 payments
  3. ORTHOCORD Sports Surgical $30,795 10 payments
  4. N/A $30,795 10 payments
  5. INTRAFIX Sports Surgical $30,795 10 payments
  6. HEALIX $24,099 9 payments
  7. ORTHOCORD Sports Surgical $24,063 8 payments
  8. INTRAFIX Sports Surgical $24,063 8 payments
  9. CAPITAL EQUIPMENT CART $24,063 8 payments
  10. BioBrace 23mm Oww $17,600 3 payments
  11. Other $57,666 78 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

99

Median for Sports Medicine: 144

Drug cost

$490

Median for Sports Medicine: $1,027

Branded share of claims

0%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 31 $313
Meloxicam Generic 68 $177

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 52 billing codes

Paid by Medicare

$151,311

Of which drugs: $14,450

Medicare patients

535

Average age 73

Services billed

2,011

305 women, 230 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 62%
Ischemic heart disease 32%
Diabetes 26%
Osteoporosis 23%
Depression 19%
Cancer 18%
COPD 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose J7326 Office 27 33 $12,041
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 153 820 $609

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

135 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record